Yue Da International to Acquire 52% Stake in Organoid Technology Firm

MT Newswires Live

2025/05/01

Yue Da International (HKG:0629) entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.

The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.

The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.

The parties are yet to enter into a formal agreement regarding the acquisitions.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2532713880"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2532713880\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2532713880?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-01 20:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2532713880","market":"nz","top_or_hot":-1,"title":"Yue Da International to Acquire 52% Stake in Organoid Technology Firm","media":"MT Newswires Live","content":"<html><body><p> Yue Da International (HKG:0629) entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.</p><p>The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.</p><p>The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.</p><p>The parties are yet to enter into a formal agreement regarding the acquisitions.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yue Da International to Acquire 52% Stake in Organoid Technology Firm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYue Da International to Acquire 52% Stake in Organoid Technology Firm\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-05-01 20:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Yue Da International (HKG:0629) entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.</p><p>The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.</p><p>The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.</p><p>The parties are yet to enter into a formal agreement regarding the acquisitions.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00629","symbol_name":"悦達國際控股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2532713880","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2532713880","pubTimestamp":1746101256,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Yue Da International  entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.The parties are yet to enter into a formal agreement regarding the acquisitions.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00629":"悦达国际控股","BK1186":"特殊金融服务"},"translate_title":"悦达国际将收购类器官技术公司52%股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00629":0.9},"content_text":"Yue Da International (HKG:0629) entered into a non-legal binding term sheet to potentially acquire a 52% total equity interest in Chengdu Organoidmed Medical Laboratory, a Wednesday Hong Kong bourse filing said.The firm will purchase a 30% equity stake through a capital injection of around 30 million yuan and a 22% equity interest from seller Shenzhen Jingke Biotechnology for 22 million yuan.The target company engages mainly in the development of organoid technology and the application of organoid technology in precision tumor medicine.The parties are yet to enter into a formal agreement regarding the acquisitions.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}